Cargando…
Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis
Developing new effective treatment strategies to overcome the rise in multi-drug resistant tuberculosis cases (MDR-TB) represents a global challenge. A host-directed therapy (HDT), acting on the host immune response rather than Mtb directly, could address these resistance issues. We developed an HDT...
Autores principales: | Bahlool, Ahmad Z., Fattah, Sarinj, O’Sullivan, Andrew, Cavanagh, Brenton, MacLoughlin, Ronan, Keane, Joseph, O’Sullivan, Mary P., Cryan, Sally-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415714/ https://www.ncbi.nlm.nih.gov/pubmed/36015371 http://dx.doi.org/10.3390/pharmaceutics14081745 |
Ejemplares similares
-
Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021) -
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
por: Bahlool, Ahmad Z., et al.
Publicado: (2022) -
Cellular Therapy for the Treatment of Paediatric Respiratory Disease
por: Brennan, Laura C., et al.
Publicado: (2021) -
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021) -
In vitro evaluation of disposable transport ventilators with combination aerosol therapy
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)